SCHEMBL368452

SCHEMBL368452

N[C@H](Cc1ccccc1)C(=O)N1CCCC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 5/20 0.69
DPP7 Q9UHL4 5/20 0.62
HPGD P15428 2/20 0.60
TSHR P16473 2/20 0.60
GAA P10253 1/20 0.60
ALPI P09923 1/20 0.58
PKM P14618 1/20 0.58
PTGS1 P23219 1/20 0.58
XIAP P98170 1/20 0.58
SLC7A5 Q01650 1/20 0.58
DPP4 P27487 4/20 0.57
DPP8 Q6V1X1 2/20 0.57
DPP9 Q86TI2 2/20 0.57
FAP Q12884 1/20 0.57
AKT1 P31749 3/20 0.56
PLAU P00749 1/20 0.56
PLAUR Q03405 1/20 0.56
OPRD1 P41143 1/20 0.56
AKT2 P31751 1/20 0.56
AKT3 Q9Y243 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1040335 1.00 HDAC8 (0.69) HDAC8DPP7HPGDTSHRGAA
SCHEMBL1619160 1.00 HDAC8 (0.69) HDAC8DPP7HPGDTSHRGAA
SCHEMBL8077871 0.98 HDAC8 (0.68) HDAC8DPP7HPGDTSHRGAA
SCHEMBL1039399 0.98 HDAC8 (0.68) HDAC8DPP7HPGDTSHRGAA
Bromide SCHEMBL8750830 0.95 HDAC8 (0.68) HDAC8DPP7HPGDTSHRGAA
Trifluoroacetic Acid SCHEMBL5406881 0.93 HDAC8 (0.61) HDAC8DPP7HPGDTSHRGAA
Trifluoroacetic Acid SCHEMBL6350937 0.91 HDAC8 (0.59) HDAC8DPP7HPGDTSHRGAA
SCHEMBL7506193 0.91 DPP4 (0.70) HDAC8DPP7HPGDTSHRGAA
SCHEMBL10305133 0.91 DPP4 (0.70) HDAC8DPP7HPGDTSHRGAA
Piperidine SCHEMBL9052483 0.89 HDAC8 (0.59) HDAC8DPP7HPGDTSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2481407-A1 Compounds for use in treating cognitive disorders Allergan, Inc. (US) 2012-08-01 EP disclosed
EP-2198864-B1 Pharmaceutical compositions having an analgesic effect and containing 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides or related compounds ALLERGAN INC (US) 2012-03-14 EP disclosed
EP-2198864-A1 Pharmaceutical compositions having an analgesic effect and containing 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides or related compounds Allergan, Inc. (US) 2010-06-23 EP disclosed
WO-2008011487-A2 L-BENZYL-L-HYDR0XY-2, 3-DIAMIN0-PROPYL AMINES AND 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONICACID AMIDES FOR CHRONIC PAIN ALLERGAN, INC. (US) 2008-01-24 WO disclosed